Biolife Solutions Stock Alpha and Beta Analysis
| BLFS Stock | USD 27.06 0.29 1.08% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as BioLife Solutions. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioLife Solutions over a specified time horizon. Remember, high BioLife Solutions' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioLife Solutions' market risk premium analysis include:
Beta 1.73 | Alpha (0.06) | Risk 3.81 | Sharpe Ratio 0.0455 | Expected Return 0.17 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioLife |
BioLife Solutions Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioLife Solutions market risk premium is the additional return an investor will receive from holding BioLife Solutions long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioLife Solutions. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioLife Solutions' performance over market.| α | -0.06 | β | 1.73 |
BioLife Solutions expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioLife Solutions' Buy-and-hold return. Our buy-and-hold chart shows how BioLife Solutions performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BioLife Solutions Market Price Analysis
Market price analysis indicators help investors to evaluate how BioLife Solutions stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioLife Solutions shares will generate the highest return on investment. By understating and applying BioLife Solutions stock market price indicators, traders can identify BioLife Solutions position entry and exit signals to maximize returns.
BioLife Solutions Return and Market Media
The median price of BioLife Solutions for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 24.17 with a coefficient of variation of 5.99. The daily time series for the period is distributed with a sample standard deviation of 1.45, arithmetic mean of 24.21, and mean deviation of 1.17. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 3070 shares by Richardson Garrie of BioLife Solutions at 25.12 subject to Rule 16b-3 | 09/16/2024 |
2 | Biolife Solutions CFO sells shares worth over 35k | 09/18/2024 |
3 | Disposition of 10000 shares by Aby Mathew of BioLife Solutions at 2.06 subject to Rule 16b-3 | 09/19/2024 |
4 | Disposition of 894 shares by Troy Wichterman of BioLife Solutions at 23.15 subject to Rule 16b-3 | 10/30/2024 |
5 | Biolife solutions chief human resources officer sells 4,699 in stock | 11/01/2024 |
6 | Canopy Growth Corporation Reports Q2 Loss, Misses Revenue Estimates | 11/08/2024 |
7 | What To Expect From BioLife Solutions Inc Q3 2024 Earnings | 11/11/2024 |
8 | BioLife Solutions GAAP EPS of -0.04 beats by 0.04, revenue of 30.6M beats by 5.2M | 11/12/2024 |
9 | BioLife Solutions Inc Shares Up 1.74 percent on Nov 13 | 11/13/2024 |
10 | BioLife Solutions executive Karen Foster sells 1,738 in stock | 11/14/2024 |
11 | BioLife Solutions, Inc. Just Reported And Analysts Have Been Cutting Their Estimates | 11/15/2024 |
12 | BioLife Solutions stock target cut, keeps Buy rating on subsidiaries sales | 11/18/2024 |
13 | BioLife Solutions Stock Price Up 6.7 percent Heres What Happened | 11/22/2024 |
About BioLife Solutions Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioLife or other stocks. Alpha measures the amount that position in BioLife Solutions has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.002006 | 0.001426 | Price To Sales Ratio | 4.96 | 4.71 |
BioLife Solutions Upcoming Company Events
As portrayed in its financial statements, the presentation of BioLife Solutions' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, BioLife Solutions' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of BioLife Solutions' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of BioLife Solutions. Please utilize our Beneish M Score to check the likelihood of BioLife Solutions' management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with BioLife Solutions
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.